Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachel Mok

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
The Lancet. Infectious Diseases|March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection studyBridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.
Cell Chemical Biology|January 25, 2020
The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum ParasitesEuna Yoo, Christopher J Schulze, Barbara H Stokes, et al.
Journal of Medicinal Chemistry|February 23, 2021
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in <i>Plasmodium falciparum</i>Aloysus Lawong, Suraksha Gahalawat, John Okombo, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Science Advances|November 8, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Nature Communications|May 27, 2023
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparumKrittikorn Kümpornsin, Theerarat Kochakarn, Tomas Yeo, et al.
ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II <i>P. falciparum</i> genetic crossMariko Kanai, Sachel Mok, Tomas Yeo, et al.
Scientific Reports|January 23, 2021
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasitesDorjbal Dorjsuren, Richard T Eastman, Kathryn J Wicht, et al.
Research Square|November 24, 2025
Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistanceJohn Okombo, Tolla Ndiaye, Tarrick Qahash, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Lancet. Infectious Diseases|March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection studyBridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.
Cell Chemical Biology|January 25, 2020
The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum ParasitesEuna Yoo, Christopher J Schulze, Barbara H Stokes, et al.
Journal of Medicinal Chemistry|February 23, 2021
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in <i>Plasmodium falciparum</i>Aloysus Lawong, Suraksha Gahalawat, John Okombo, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Science Advances|November 8, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Nature Communications|May 27, 2023
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparumKrittikorn Kümpornsin, Theerarat Kochakarn, Tomas Yeo, et al.
ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II <i>P. falciparum</i> genetic crossMariko Kanai, Sachel Mok, Tomas Yeo, et al.
Scientific Reports|January 23, 2021
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasitesDorjbal Dorjsuren, Richard T Eastman, Kathryn J Wicht, et al.
Research Square|November 24, 2025
Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistanceJohn Okombo, Tolla Ndiaye, Tarrick Qahash, et al.
Pageof 7